International Neuromodulation Society
The International Neuromodulation Society is a 501(c)(3) nonprofit founded in 1989 that serves 3,000+ clinicians, scientists, and engineers across 60 countries through a peer-reviewed journal, global congresses, and 20+ regional chapters devoted to advancing neuromodulation science and education.
- Company typePrivate
- Founded1989
- HeadquartersSan Francisco, United States
- Headcount1–10
- GTM typeB2B and B2C
- OfferingServices
What International Neuromodulation Society does
The International Neuromodulation Society (INS) is a 501(c)(3) nonprofit professional society founded in 1989 and headquartered in San Francisco, California. It is the oldest and largest multidisciplinary body dedicated to neuromodulation — the alteration of nerve activity through targeted delivery of electrical stimulation or chemical agents to specific neurological sites. The INS serves clinicians, scientists, and bioengineers across neurology, neurosurgery, neurophysiology, pain management, and related disciplines, with 3,000+ members in approximately 60 countries organized through 20+ affiliated regional chapters spanning North America, South America, Europe, Asia, and Oceania. Secondary audiences include patients and caregivers, payers and policy makers, and medical journalists seeking credible information about neuromodulation therapies.
The society's core offerings center on a peer-reviewed scientific journal, recurring congresses, and digital education channels. Neuromodulation: Technology at the Neural Interface is the only MEDLINE-indexed journal dedicated exclusively to the field and has been published since 1998, currently distributed through Wiley. The annual World Congress (17th edition scheduled for Lisbon, May 9-14, 2026) and an interim meeting form the in-person scientific backbone, complemented by webinars, a Virtual Journal Club, hands-on workshops, and The Neuromodulation Podcast. Patient-facing services include condition-specific fact sheets, a searchable clinical trials database, and a Find a Clinic directory. The society is led by an Executive Director (Tia Sofatzis), a Board of Directors, and an elected President (currently Marc Russo), with a lean operating team of 1-10 staff.
The business model is a multi-stream nonprofit funding structure rather than a commercial sales motion. Revenue is generated through member dues, conference and interim meeting registration/exhibition proceeds, royalties from the Wiley-published journal, and unrestricted educational grants from neuromodulation device manufacturers including Abbott, Boston Scientific, Mainstay Medical, Medtronic, Nalu Medical, Nevro Corp., and Saluda Medical. Distribution occurs primarily through neuromodulation.com, regional chapter websites, Wiley Online Library, social media channels, and in-person congresses. The society's go-to-market motion is community-led: growth is driven by member recruitment, scientific reputation, chapter development, and the credibility of its peer-reviewed publication rather than direct sales or paid marketing.
International Neuromodulation Society firmographics
Firmographics- Name
- International Neuromodulation Society
- Legal name
- International Neuromodulation Society
- Website
- https://neuromodulation.com
- Company type
- Private
- Founded year
- 1989
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- The International Neuromodulation Society is a 501(c)(3) nonprofit founded in 1989 that serves 3,000+ clinicians, scientists, and engineers across 60 countries through a peer-reviewed journal, global congresses, and 20+ regional chapters devoted to advancing neuromodulation science and education.
- Ownership category
- akta.pro rank
Where International Neuromodulation Society is headquartered
LocationHeadquarters
- HQ city
- San Francisco
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
International Neuromodulation Society business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Marketing or Sales, Technology or R&D, Others
Revenue model
- Member Dues: The society collects membership dues from clinicians, scientists, and engineers who join as members.
- Conference Proceeds: Revenue generated from the INS World Congress and interim meetings, including registration fees and exhibition revenue.
- Journal Royalties: Royalties from the peer-reviewed journal Neuromodulation: Technology at the Neural Interface published by Wiley.
- Unrestricted Grants from Industry: The website is supported by unrestricted grants from Abbott, Boston Scientific Corporation, Mainstay Medical, Medtronic Inc., Nalu Medical, Nevro Corp., and Saluda Medical. These are charitable contributions that support website operations.
Go-to-market motion1 record
Distribution channels4 records
Marketing channels9 records
International Neuromodulation Society product offering
Product offeringCore offering
The International Neuromodulation Society is a nonprofit professional medical society that advances the science, education, and practice of neuromodulation through a peer-reviewed journal, international congresses, webinars, podcasts, and a global network of regional chapters for clinicians, scientists, and engineers. It also delivers patient-facing educational resources including fact sheets, a clinic finder, and a clinical trials directory.
Product overview
The International Neuromodulation Society is a nonprofit professional medical society, not a technology product company. Its offerings consist of membership services and educational resources for healthcare professionals and patients. The core portfolio includes the peer-reviewed journal 'Neuromodulation: Technology at the Neural Interface' (indexed in MEDLINE since 1998), the World Congress (17th scheduled for May 2026 in Lisbon) and Interim Meetings, webinars, workshops, the Neuromodulation Podcast, and INS Regional Chapters spanning over 20 countries. Patient-facing services include fact sheets, clinical trials listings, and a clinic finder directory. The society operates member-only resources with mentorship programs and expert panels. The society does not offer commercial technology products or AI-powered solutions.
Differentiator
Problem solved
Functional benefit
Brands
- Neuromodulation: Technology at the Neural Interface: The official peer-reviewed journal of the International Neuromodulation Society, publishing scientific works and reviews on neuromodulation.
Products and services
- Neuromodulation: Technology at the Neural Interface (Journal) The official MEDLINE-indexed peer-reviewed journal of the INS, publishing scientific works and reviews on neuromodulation research; available to members online and via Wiley for non-members.
- INS World Congress Flagship biennial international scientific meeting bringing together clinicians, scientists, and engineers for scientific presentations, workshops, and networking in neuromodulation.
- INS Interim Meeting Intermediate scientific meeting held between World Congresses, providing additional education and collaboration opportunities for neuromodulation professionals.
- INS Webinars Online educational webinars providing continuing education and the latest research updates for INS members and healthcare professionals.
- Virtual Journal Club Online forum for discussion and analysis of recent peer-reviewed journal articles in neuromodulation.
- INS Workshops Hands-on training workshops for medical professionals covering neuromodulation techniques and procedures.
- The Neuromodulation Podcast Podcast series featuring discussions on emerging neuromodulation techniques, insights, ethical and clinical applications, and multidisciplinary collaboration.
- INS Regional Chapters Network of 20+ affiliated national chapters spanning Argentina, Australia & New Zealand, Benelux, Brazil, Canada, China, Colombia, France, Germany, Italy, Japan, Korea, Nordic countries, Poland, Russia, South East Europe, Spain, Switzerland, Turkey, UK and Ireland.
- INS Membership Services Member-only resources including journal access, mentorship programs, expert panels, educational materials, and industry news.
- Find a Clinic Directory Directory service helping patients locate clinics offering neuromodulation treatments.
- INS Fact Sheets Patient-focused educational fact sheets on neuromodulation therapies including deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, epilepsy, and Parkinson's disease.
- Clinical Trials Listings Searchable database of clinical trials involving neuromodulation approaches across chronic pain, movement disorders, epilepsy, psychiatric disorders, brain injury, stroke, cardiovascular, gastrointestinal, and other conditions.
Companies that use International Neuromodulation Society
Customer profileNamed customers1 record
Segments4 records
Ideal customer profiles3 records
International Neuromodulation Society technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
International Neuromodulation Society partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Wiley (Journal Publisher)coreThe INS journal Neuromodulation: Technology at the Neural Interface is published by Wiley. The journal is indexed in Index Medicus, MEDLINE and Pubmed from its first issue in 1998 and has a growing Impact Factor.
Scale indicators2 records
Recent moves6 records
Expansion highlights4 records
International Neuromodulation Society competitors and assessment
Company assessmentRegional players
- European Academy of Neurology (EAN): Pan-European neurology professional society comparable to AAN in scope and structure, with neuromodulation as a covered subspecialty. Operates regional congresses and a peer-reviewed journal (European Journal of Neurology), serving an overlapping European clinician audience that INS reaches through its European regional chapters.
Broad incumbents
- American Association of Neurological Surgeons (AANS): Major US neurosurgical professional society with significant neuromodulation content (DBS, SCS, etc.) and a dedicated section on pain and neuromodulation. Comparable in operating model (membership, journal Neurosurgery, annual meeting) but much broader specialty focus.
- American Academy of Neurology (AAN): Largest US-based neurology professional society, covering neuromodulation as part of a much broader specialty. Comparable society/membership/journal/congress model but operates at vastly larger scale; many INS members also belong to AAN, making it both a competitor and a partner ecosystem.
- World Federation of Neurosurgical Societies (WFNS): International umbrella society for national neurosurgical organizations worldwide. Overlaps with INS on the neurosurgical neuromodulation community, congress programming, and journal publication, but covers all of neurosurgery rather than specializing in neuromodulation.
- Society for Neuroscience (SfN): Massive US-based neuroscience professional society covering the basic science underlying neuromodulation. Operates a top-tier journal (Journal of Neuroscience) and annual meeting far larger than INS's, but encompasses neuromodulation as a subset of a much broader research remit.
Direct peers
- American Neurological Association (ANA): US-based academic neurology professional society with peer-reviewed journal (Annals of Neurology) and annual meeting. Comparable in mission and membership model to INS, with significant overlap on the academic neurology researchers who participate in neuromodulation clinical trials.
- International Association for the Study of Pain (IASP): Global multidisciplinary professional society focused on pain research and treatment, with spinal cord stimulation and other neuromodulation modalities as a major interest area. Operates a peer-reviewed journal, congresses, and chapters — closely comparable to INS in structure, membership model, and clinical scope.
- North American Neuromodulation Society (NANS): Direct peer and INS's North American chapter-affiliated society, also focused on neuromodulation education, research dissemination, and physician membership. Operates its own journal, annual meeting, and continuing education for neuromodulation clinicians — directly overlapping INS's core mission and audience.
- International Parkinson and Movement Disorder Society (MDS): International scientific society for clinicians and researchers in movement disorders, including deep brain stimulation — a major neuromodulation application INS also covers. Comparable membership size, journal (Movement Disorders), and congress-driven business model, serving an overlapping physician audience.
- International League Against Epilepsy (ILAE): International professional society for epilepsy clinicians and researchers, with vagus nerve stimulation and responsive neurostimulation as core neuromodulation topics within its scope. Operates with the same society/journal/congress model and serves an overlapping neuroscience community.
Market position
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
International Neuromodulation Society social profiles
Digital presenceInternational Neuromodulation Society financial estimates
Financial estimateRevenue estimate
Valuation estimate
International Neuromodulation Society leadership team
Management profileNumber of profiles
Profiles2 records
International Neuromodulation Society funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
International Neuromodulation Society M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about International Neuromodulation Society
What does International Neuromodulation Society do?
The International Neuromodulation Society is a nonprofit professional medical society that advances the science, education, and practice of neuromodulation through a peer-reviewed journal, international congresses, webinars, podcasts, and a global network of regional chapters for clinicians, scientists, and engineers. It also delivers patient-facing educational resources including fact sheets, a clinic finder, and a clinical trials directory.
Is International Neuromodulation Society a public or private company?
International Neuromodulation Society is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was International Neuromodulation Society founded?
International Neuromodulation Society was founded in 1989. It employs 1 to 10 people.
Where is International Neuromodulation Society based?
International Neuromodulation Society is headquartered in San Francisco, United States, in the North America region.
How does International Neuromodulation Society make money?
Four revenue lines are on record. Member Dues are the primary driver. The others are conference Proceeds, journal Royalties and unrestricted Grants from Industry.
Who are International Neuromodulation Society's main competitors?
European Academy of Neurology (EAN) is listed as a regional player. Broad incumbents are American Association of Neurological Surgeons (AANS), American Academy of Neurology (AAN), World Federation of Neurosurgical Societies (WFNS) and Society for Neuroscience (SfN). Direct peers are American Neurological Association (ANA), International Association for the Study of Pain (IASP), North American Neuromodulation Society (NANS), International Parkinson and Movement Disorder Society (MDS) and International League Against Epilepsy (ILAE).
Does International Neuromodulation Society have an API?
No public API is recorded for International Neuromodulation Society.